GlassScriptPhysician profile
Najam Saqib
NPI 1740711100
$12,785.90
in general payments reported to CMS, 2019-2025
26 companies · $3,461 in 2025
The $3,461 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.49 · 2020: $770 · 2021: $202 · 2022: $3,104 · 2023: $3,423 · 2024: $1,796 · 2025: $3,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,500 · Travel and Lodging: $4,107 · Education: $74.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,499.55 |
| Travel and Lodging | $4,106.54 |
| Education | $74.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,984.20 | 2022-2025 | Watchman Access System, Avvigo Guidance System, Eluvia |
| Medtronic, INC. | $2,032.26 | 2022-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,820.41 | 2025 | Evoque |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $986.37 | 2019-2024 | Lifevest |
| Inari Medical, INC. | $589.44 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $528.99 | 2024 | Cardiomems, Coroflow, Xience Skypoint |
| Abiomed | $272.22 | 2023-2024 | Impella |
| Teleflex LLC | $261.31 | 2023-2024 | Guideliner, Turnpike |
| Amgen INC. | $228.08 | 2020-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $201.44 | 2020-2025 | Eliquis, Camzyos |
| Cook Incorporated | $140.85 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $123.66 | 2020 | |
| Penumbra, INC. | $111.06 | 2023 | Indigo System |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $66.25 | 2024 | |
| Medical Device Business Services, INC. | $53.17 | 2024 | Carto 3 |
| Pfizer INC. | $38.44 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.30 | 2025 | Jardiance |
| Tactile Systems Technology INC | $31.65 | 2025 | Nimbl, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $28.86 | 2021 | |
| Shockwave Medical, INC | $26.75 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $21.08 | 2024 | |
| Kestra Medical Technology Services, INC. | $19.12 | 2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $16.24 | 2024 | Nexletol |
| Scpharmaceuticals INC. | $15.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najam Saqib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.